Abstract: The invention relates to a composition for treating or preventing prostate cancer or the recurrence thereof; including a non-aqueous extract of non-germinated broccoli seeds of the Brassica Oleracea Italica variety that are rich in sulforaphane. The extract is encapsulated by a compound selected from the group including acacia gum, maltodextrin, and the mixture thereof, and said composition can be provided in the form of a capsule, tablet, sugarcoated tablet, or film-coated tablet, and is orally administered one to three times a day at a daily dose of 2 to 200 mg.

Abstract: A biodegradable film (4) characterized in that it is prepared from at least one co-product derived from a soya bean-processing process aimed at obtaining soya-based final products by ultrafiltration, said co-product being selected from the group comprising the okara and the permeate. Such a film can be used as a food or pharmaceutical film, in particular for preparing a product for topical administration (1) of a pharmaceutical active ingredient, such as oestrogens.

Abstract: The invention relates to a sanitary device (1) for applying at least one active principle inside a human or animal body cavity, said device comprising at least one biodegradable film (3) containing the at least one active substance and an applicator including: a main tubular body (4); and an ejector body (2) comprising a distal portion (202), at least one part of the surface of which forms a support for the at least one biodegradable film (3) and the end (203) of which is rounded, whereby said ejector body (2) can slide inside the main body (4) between at least one position in which the distal portion (202) of the ejector body (2) is located inside the main body (4) and an application position in which the distal portion (202) is located outside same, in the axial extension of the main body (4).

Abstract: A biodegradable film (4) characterized in that it is prepared from at least one co-product derived from a soya bean-processing process aimed at obtaining soya-based final products by ultrafiltration, said co-product being selected from the group comprising the okara and the permeate. Such a film can be used as a food or pharmaceutical film, in particular for preparing a product for topical administration (1) of a pharmaceutical active ingredient, such as oestrogens.